Back
ImmunityBio Stock Price Chart
Sponsored
IBRX
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52
IBRX
ImmunityBio
Last Price:
5.04
Seasonality Move:
73.14%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IBRX is experiencing selling pressure, which indicates risk of future bearish movement.
ImmunityBio Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.98 | Sell |
20-day SMA: | 5.21 | Sell |
50-day SMA: | 4.21 | Buy |
200-day SMA: | 5.27 | Sell |
8-day EMA: | 5.02 | Sell |
20-day EMA: | 4.91 | Sell |
50-day EMA: | 4.6 | Buy |
200-day EMA: | 4.72 | Buy |
ImmunityBio Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.2 | Buy |
Relative Strength Index (14 RSI): | 51.13 | Buy |
Chaikin Money Flow: | -3513388 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.12 - 5.64) | Sell |
Bollinger Bands (100): | (3.54 - 5.6) | Buy |
ImmunityBio Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for ImmunityBio Stock
Is ImmunityBio Stock a Buy?
- ImmunityBio share price is 4.88 while IBRX 8-day simple moving average is 4.98, which is a Sell signal.
- The stock price of IBRX is 4.88 while ImmunityBio 20-day SMA is 5.21, which makes it a Sell.
- ImmunityBio 50-day simple moving average is 4.21 while IBRX share price is 4.88, making it a Buy technically.
- IBRX stock price is 4.88 and ImmunityBio 200-day simple moving average is 5.27, creating a Sell signal.
IBRX Technical Analysis vs Fundamental Analysis
Buy
52
ImmunityBio (IBRX)
is a Buy
Is ImmunityBio a Buy or a Sell?
-
ImmunityBio stock is rated a Buy
The current ImmunityBio [IBRX] share price is $4.88. The Score for IBRX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
ImmunityBio Stock Info
Market Cap:
3.4B
Price in USD:
4.88
Share Volume:
5.01M
ImmunityBio 52-Week Range
52-Week High:
10.53
52-Week Low:
3.10
Buy
52
ImmunityBio (IBRX)
is a Buy
ImmunityBio Share Price Forecast
-
What is the ImmunityBio stock price today?
The ImmunityBio stock price is 4.88 USD today. -
Will IBRX stock go up or go down?
ImmunityBio> share price is forecast to RISE/FALL based on technical indicators -
Is ImmunityBio overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, ImmunityBio is not overvalued.
Is ImmunityBio Stock a Buy?
- ImmunityBio share price is 4.88 while IBRX 8-day exponential moving average is 5.02, which is a Sell signal.
- The stock price of IBRX is 4.88 while ImmunityBio 20-day EMA is 4.91, which makes it a Sell.
- ImmunityBio 50-day exponential moving average is 4.60 while IBRX share price is 4.88, making it a Buy technically.
- IBRX stock price is 4.88 and ImmunityBio 200-day simple moving average is 4.72, creating a Buy signal.
Fundamental Analysis of ImmunityBio
Is ImmunityBio a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.32 per share.
Technical Analysis of ImmunityBio
Should I short ImmunityBio stock?
- IBRX Moving Average Covergence Divergence (MACD) indicator is 0.2, suggesting ImmunityBio is a Buy
- ImmunityBio Relative Strength Index (RSI) is 51.13, which suggest ImmunityBio is overbought
- The Bollinger Bands (25) for ImmunityBio is (4.12 - 5.64), which suggest ImmunityBio is a Buy
- The Bollinger Bands (100) for ImmunityBio is (3.54 - 5.6), which suggest ImmunityBio is a Buy
* ImmunityBio stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.